Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07600684 · ClinicalTrials.gov registry record · NA
Preventing Medication Mismanagement in People Living With Dementia
A NA study, sponsored by HiDO Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07600684: Recruiting NA study, sponsored by HiDO Technologies.
NCT07600684 is a NA study that is actively recruiting participants, run by HiDO Technologies. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07600684, a NA study, is actively recruiting participants, sponsored by HiDO Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this research is to learn whether the HiDO-ALZ device can improve medication compliance and health outcomes in participants with dementia that need to take daily medication.
Primary Outcome
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a standardized assessment used to evaluate the severity of cognitive dysfunction. The total score is derived from multiple cognitive domains, including memory, language, praxis, and orientation. Change from baseline to the specified assessment timepoint will be analyzed, with higher scores indicating greater cognitive impairment.
Interventions
- DEVICE HiDO HomeCareSystem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05-05 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07600684 shows while recruiting
NCT07600684 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which HiDO HomeCareSystem is the first listed.
NCT07600684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07600684 about?
NCT07600684 is a clinical study titled "Preventing Medication Mismanagement in People Living With Dementia". The purpose of this research is to learn whether the HiDO-ALZ device can improve medication compliance and health outcomes in participants with dementia that need to take daily medication.
What is the current status of trial NCT07600684?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-05-05. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07600684?
The interventions under investigation include: HiDO HomeCareSystem (DEVICE).
Who is sponsoring clinical trial NCT07600684?
This trial is sponsored by HiDO Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07600684's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI